Cancer cells maintain high pools of glutamine by upregulating the expression of glutamine transporters, such as Alanine/Serine/Cysteine/Threonine Transporter 2 (ASCT2; SLC1A5) in PC and SLC7A5 in HC. Here, SLC1A5 is linked to cancer.